Mechanisms involved in the antiplatelet activity of simvastatin
碩士 === 臺北醫學大學 === 藥理學研究所 === 95 === Simvastatin is a specific inhibitor of 3 hydroxy-3-methylglutaryl coenzyme A (HMG CoA) reductase. It is capable of lowering plasma cholesterol and has successfully used in the clinical treatment of hypercholesterolemia. Recent studies have shown that the effects o...
Main Authors: | Ssu-Yu Hou, 侯思伃 |
---|---|
Other Authors: | 許準榕 |
Format: | Others |
Language: | zh-TW |
Published: |
2007
|
Online Access: | http://ndltd.ncl.edu.tw/handle/87446740631033971719 |
Similar Items
-
Mechanisms Involved in the Antiplatelet Activity of Resveratrol
by: Chang-Lin Liu, et al.
Published: (2005) -
Mechanisms involved in the antiplatelet activity of inosine
by: Lin Kuan-Hung, et al.
Published: (2003) -
Mechanisms involved in the antiplatelet activity of lycopene
by: 王英
Published: (2003) -
Mechanisms involved in the antiplatelet activity of tetramethylpyrazine
by: KAN Ya-Chen, et al.
Published: (1998) -
Mechanisms involved in the antiplatelet activity of GABA
by: Yung-Chen Chiang, et al.
Published: (2010)